学术探索
学术期刊
新闻热点
数据分析
智能评审

Tetrabenazine as a cause of neuroleptic malignant syndrome

被引：29
作者：
Ossemann, M
Sindic, CJM
Laterre, C
机构：
来源：
MOVEMENT DISORDERS | 1996年 / 11卷 / 01期
关键词：
D O I：
10.1002/mds.870110118
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：95 / 95
页数：1
相关论文
共 5 条
[1]   NEUROLEPTIC MALIGNANT SYNDROME CAUSED BY DOPAMINE-DEPLETING DRUGS IN A PATIENT WITH HUNTINGTON DISEASE [J].
BURKE, RE ;
FAHN, S ;
MAYEUX, R ;
WEINBERG, H ;
LOUIS, K ;
WILLNER, JH .
NEUROLOGY, 1981, 31 (08) :1022-1026
[2]   PATHOGENESIS AND TREATMENT OF NEUROLEPTIC MALIGNANT SYNDROME [J].
EBADI, M ;
PFEIFFER, RF ;
MURRIN, LC .
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1990, 21 (04) :367-386
[3]  
Kidd D W, 1972, Br J Clin Pract, V26, P179
[4]   NEUROLEPTIC MALIGNANT SYNDROME RELATED TO TETRABENAZINE INTRODUCTION AND HALOPERIDOL DISCONTINUATION IN HUNTINGTONS-DISEASE [J].
MATEO, D ;
MUNOZBLANCO, JL ;
GIMENEZROLDAN, S .
CLINICAL NEUROPHARMACOLOGY, 1992, 15 (01) :63-68
[5]   TOLERANCE OF TETRABENAZINE DURING LONG-TERM TREATMENT [J].
MIKKELSEN, BO .
ACTA NEUROLOGICA SCANDINAVICA, 1983, 68 (01) :57-60
1